
AVITA Medical RCEL
$ 4.03
8.33%
Annual report 2025
added 02-12-2026
AVITA Medical P/CF Ratio 2011-2026 | RCEL
Annual P/CF Ratio AVITA Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.32 | -4.68 | -11.7 | -11.7 | -43.8 | -18.3 | -18.3 | -4.69 | -7.37 | -7.05 | -5.27 | -5.94 | -6.76 | -11.8 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -3.32 | -43.8 | -11.5 |
P/CF Ratio of other stocks in the Medical devices industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AxoGen
AXGN
|
190 | $ 33.91 | 3.99 % | $ 1.5 B | ||
|
Allied Healthcare Products
AHPI
|
-0.98 | - | 3.58 % | $ 2.21 M | ||
|
Apollo Endosurgery
APEN
|
-12.9 | - | - | $ 475 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-80.1 | - | - | $ 1.77 B | ||
|
Cognyte Software Ltd.
CGNT
|
14.1 | $ 6.93 | 0.87 % | $ 498 M | ||
|
Axonics Modulation Technologies
AXNX
|
885 | - | - | $ 3.31 B | ||
|
Acutus Medical
AFIB
|
-0.083 | - | -26.83 % | $ 2.62 M | ||
|
Lianluo Smart Limited
LLIT
|
-62.7 | - | 24.59 % | $ 44.8 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-3.31 | - | -5.86 % | $ 30.6 M | ||
|
Aziyo Biologics
AZYO
|
-1.24 | - | 1.37 % | $ 20.5 M | ||
|
Delcath Systems
DCTH
|
-20.1 | $ 9.27 | 1.64 % | $ 264 M | ||
|
Apyx Medical Corporation
APYX
|
-8.71 | $ 3.73 | -2.48 % | $ 129 M | ||
|
Alphatec Holdings
ATEC
|
-34.8 | $ 13.33 | 1.76 % | $ 1.91 B | ||
|
EDAP TMS S.A.
EDAP
|
-4.42 | $ 4.92 | 3.15 % | $ 183 M | ||
|
BIOLASE
BIOL
|
-0.0136 | - | -13.19 % | $ 166 K | ||
|
Electromed
ELMD
|
15.3 | $ 23.5 | 0.82 % | $ 199 M | ||
|
Bio-Rad Laboratories
BIO
|
17.2 | $ 260.94 | -10.77 % | $ 7.36 B | ||
|
Conformis
CFMS
|
-0.252 | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
0.000028 | $ 37.29 | -0.59 % | $ 5.56 K | ||
|
BioSig Technologies
BSGM
|
-1.53 | - | 37.08 % | $ 85.7 M | ||
|
CONMED Corporation
CNMD
|
11.6 | $ 42.01 | 0.82 % | $ 1.3 B | ||
|
Boston Scientific Corporation
BSX
|
45.1 | $ 74.9 | 1.05 % | $ 110 B | ||
|
Abbott Laboratories
ABT
|
27.5 | $ 111.88 | 0.37 % | $ 195 B | ||
|
Cardiovascular Systems
CSII
|
-24.2 | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
-0.337 | - | -10.19 % | $ 1.99 M | ||
|
CryoLife, Inc.
CRY
|
180 | - | -4.14 % | $ 702 M | ||
|
ClearPoint Neuro
CLPT
|
-52 | $ 13.66 | 4.75 % | $ 369 M | ||
|
CHF Solutions, Inc.
CHFS
|
-0.0621 | - | 1.15 % | $ 34.5 M | ||
|
InMode Ltd.
INMD
|
10.8 | $ 14.25 | -0.35 % | $ 1.13 B | ||
|
IRadimed Corporation
IRMD
|
26.1 | $ 100.17 | 0.33 % | $ 1.27 B | ||
|
Integer Holdings Corporation
ITGR
|
22.3 | $ 85.09 | -0.32 % | $ 2.86 B | ||
|
Soliton, Inc.
SOLY
|
-18.5 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
-1.02 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-30.7 | - | 0.03 % | $ 1.58 B | ||
|
Dynatronics Corporation
DYNT
|
6.49 | - | 14.99 % | $ 929 K | ||
|
Misonix, Inc.
MSON
|
-6.81 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-25 | - | - | $ 111 M | ||
|
Pulmonx Corporation
LUNG
|
-10.8 | $ 1.46 | 2.46 % | $ 57.1 M | ||
|
Intersect ENT, Inc.
XENT
|
-20.1 | - | - | $ 955 M | ||
|
Eargo
EAR
|
-0.145 | - | - | $ 10.2 M | ||
|
GBS
GBS
|
-0.256 | - | -0.57 % | $ 7.12 M | ||
|
Second Sight Medical Products
EYES
|
-0.0108 | - | -0.97 % | $ 54.4 M | ||
|
Penumbra
PEN
|
61.9 | $ 340.01 | 0.38 % | $ 13.1 B | ||
|
Avinger
AVGR
|
-0.18 | - | -20.74 % | $ 369 K | ||
|
FONAR Corporation
FONR
|
5.57 | $ 18.55 | 0.03 % | $ 122 M | ||
|
Insulet Corporation
PODD
|
45.8 | $ 248.55 | 3.21 % | $ 17.4 B | ||
|
Profound Medical Corp.
PROF
|
-10.3 | $ 6.34 | 1.69 % | $ 180 M | ||
|
Globus Medical
GMED
|
22 | $ 88.93 | 1.96 % | $ 12.1 B | ||
|
Sintx Technologies
SINT
|
-0.0132 | $ 2.77 | 1.84 % | $ 10.3 M | ||
|
Sensus Healthcare
SRTS
|
-91.9 | $ 3.77 | -18.92 % | $ 61.5 M |